Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6766 AL 6780

Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment

Godse S, Zhou L, Sakshi S, Singla B, Singh UP, Kumar S.

Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6.

Neurological Applications of Celery (Apium graveolens): A Scoping Review

Tan TYC, Lim XY, Norahmad NA, Chanthira Kumar H, Teh BP, Lai NM, Syed Mohamed AF.

Molecules. 2023 Aug 2;28(15):5824. doi: 10.3390/molecules28155824.

Mitophagy: A promising therapeutic target for neuroprotection during ageing and age-related diseases

Mishra E, Thakur MK.

Br J Pharmacol. 2023 Jun;180(12):1542-1561. doi: 10.1111/bph.16062. Epub 2023 Mar 14.

Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

Cerasuolo M, Di Meo I, Auriemma MC, Trojsi F, Maiorino MI, Cirillo M, Esposito F, Polito R, Colangelo AM, Paolisso G, Papa M, Rizzo MR.

Int J Mol Sci. 2023 Jun 1;24(11):9637. doi: 10.3390/ijms24119637.

Substance abuse and neurodegenerative diseases: focus on ferroptosis

Guo C, Chen L, Wang Y.

Arch Toxicol. 2023 Jun;97(6):1519-1528. doi: 10.1007/s00204-023-03505-4. Epub 2023 Apr 26.

Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review

Ortiz R, Rueda S, Di Ciano P.

Exp Clin Psychopharmacol. 2023 Oct;31(5):978-988. doi: 10.1037/pha0000659. Epub 2023 May 1.

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review

Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA.

Behav Neurol. 2023 Oct 12;2023:8825358. doi: 10.1155/2023/8825358. eCollection 2023.

Research progress of plant-derived natural alkaloids in central nervous system diseases

Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, Chen L.

Phytother Res. 2023 Nov;37(11):4885-4907. doi: 10.1002/ptr.7955. Epub 2023 Jul 16.

Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis

d'Angremont E, Begemann MJH, van Laar T, Sommer IEC.

JAMA Neurol. 2023 Aug 1;80(8):813-823. doi: 10.1001/jamaneurol.2023.1835.

Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress

Yoo YM, Joo SS.

Int J Mol Sci. 2023 Jan 25;24(3):2381. doi: 10.3390/ijms24032381.

Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders

Nguyen TT, Nguyen-Thi PT, Nguyen THA, Ho TT, Tran NM, Van Vo T, Van Vo G.

Mol Diagn Ther. 2023 Jul;27(4):457-473. doi: 10.1007/s40291-023-00654-1. Epub 2023 May 22.

New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases

Wang C, Cui Y, Xu T, Zhou Y, Yang R, Wang T.

Biochem Pharmacol. 2023 Dec;218:115923. doi: 10.1016/j.bcp.2023.115923. Epub 2023 Nov 18.

Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases

Makarov M, Korkotian E.

Toxins (Basel). 2023 Mar 6;15(3):202. doi: 10.3390/toxins15030202.

ER-phagy in neurodegeneration

Hill MA, Sykes AM, Mellick GD.

J Neurosci Res. 2023 Oct;101(10):1611-1623. doi: 10.1002/jnr.25225. Epub 2023 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias